v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net earnings $ 74,111 $ 49,192 $ 73,831
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Impairment of equity method investment and related party notes (13,087) 0 0
Depreciation and amortization 26,592 16,457 13,312
Stock-based compensation 6,813 3,740 3,486
Amortization of deferred financing costs 1,547 151 33
Deferred income taxes benefit/(expense) 1,379 (6,267) (3,872)
Net unrealized (gains)/losses on foreign currency revaluation (12,703) 1,456 1,356
Gains on sale/disposal of property, plant and equipment (5,701) 0 (2,117)
Gain on sale of Czech Republic business 0 0 (980)
Other, net 2,219 2,345 (1,037)
Changes in operating assets and liabilities:      
Accounts receivable (8,609) (6,817) 22,500
Unbilled receivables (4,753) 7,800 5,451
Inventories (2,415) 15,121 33,613
Other current assets (1,636) (2,357) (217)
Other assets (1,604) 5,972 2,971
Accounts payable 2,441 139 (22,745)
Accrued expenses 195 (7,068) 5,356
Accrued restructuring costs (5,078) 215 (1,228)
Other liabilities (1,617) (5,006) (16,388)
Income taxes payable (3,656) (1,009) (4,976)
Net cash provided by operating activities 80,612 74,064 108,349
Cash flows from investing activities:      
Purchase of property, plant and equipment (12,002) (14,108) (12,126)
Purchases of held to maturity U.S. Treasury securities 0 (131,309) (59,992)
Proceeds from held to maturity securities 950 167,907 19,918
Payment for equity method investment 0 0 (10,282)
Investment in related party notes receivable 0 (785) (2,152)
Proceeds from disposal/sale of property, plant and equipment 7,804 883 6,036
Acquisition of business, net of cash acquired 0 (320,481) 0
Proceeds from sale of business 0 0 5,063
Net cash used in investing activities (3,248) (297,893) (53,535)
Cash flows from financing activities:      
Dividends paid to common shareholders (3,465) (3,453) (3,492)
Purchase of treasury stock 0 (16,053) (105)
Deferred financing costs (681) (1,736) 0
Borrowings under revolving line of credit 0 242,500 5,000
Proceeds of long-term debt 8,000 0 0
Repayments under revolving line of credit (98,000) (15,000) (40,000)
Net cash (used in) provided by financing activities (94,146) 206,258 (38,597)
Net (decrease) increase in cash and cash equivalents (10,453) (21,118) 19,105
Cash and cash equivalents - beginning of year 68,253 89,371 70,266
Cash and cash equivalents - end of year 57,800 68,253 89,371
Effect of exchange rate changes on cash 6,329 (3,547) 2,888
Supplemental cash flow information:      
Income taxes, net of refunds received 23,731 22,952 25,056
Interest payments 14,792 5,795 4,729
Redeemable noncontrolling interest assumed in exchange for acquired net assets 0 72,354 0
ROU assets obtained in exchange for lease obligations $ 4,763 $ 6,870 $ 5,999